Longeveron/$LGVN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Longeveron
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
Ticker
$LGVN
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
25
ISIN
US54303L2034
Website
Longeveron Metrics
BasicAdvanced
$18M
-
-$2.04
0.21
-
Price and volume
Market cap
$18M
Beta
0.21
52-week high
$2.24
52-week low
$1.14
Average daily volume
126K
Financial strength
Current ratio
5.608
Quick ratio
5.27
Long term debt to equity
3.87
Total debt to equity
7.547
Management effectiveness
Return on assets (TTM)
-72.08%
Return on equity (TTM)
-167.59%
Valuation
Price to revenue (TTM)
6.921
Price to book
1.07
Price to tangible book (TTM)
1.24
Price to free cash flow (TTM)
-0.929
Growth
Revenue change (TTM)
127.51%
Earnings per share change (TTM)
-78.50%
3-year revenue growth (CAGR)
19.62%
3-year earnings per share growth (CAGR)
-38.60%
What the Analysts think about Longeveron
Majority rating from 2 analysts.
Longeveron News
AllArticlesVideos
Longeveron® to Attend BIO International Convention 2025
GlobeNewsWire·3 weeks ago
Longeveron® Named XPRIZE Healthspan Semifinalist and Top 40 Milestone 1 Award Recipient
GlobeNewsWire·4 weeks ago
Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Longeveron stock?
Longeveron (LGVN) has a market cap of $18M as of June 09, 2025.
What is the P/E ratio for Longeveron stock?
The price to earnings (P/E) ratio for Longeveron (LGVN) stock is 0 as of June 09, 2025.
Does Longeveron stock pay dividends?
No, Longeveron (LGVN) stock does not pay dividends to its shareholders as of June 09, 2025.
When is the next Longeveron dividend payment date?
Longeveron (LGVN) stock does not pay dividends to its shareholders.
What is the beta indicator for Longeveron?
Longeveron (LGVN) has a beta rating of 0.21. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.